Impact assessment of pharmacovigilance-related educational intervention on nursing students’ knowledge, attitude and practice: A pre-post study

Subish Palaian, Mohamed Izham Mohamed Ibrahim, Pranaya Mishra, Pathiyil Ravi Shankar


Objective: This study evaluated the impact of a pharmacovigilance education module for nursing students.

Methods: In this prospective, pre-post interventional study, the 2nd year diploma in Nursing students (n = 38) were the ‘test’ group (who received intervention), and the 1st and 3rd year students were the control group (n = 78); total n = 116.  Knowledge Attitude Practice (KAP) responses were taken at baseline (0 day), 30 days, 90 days and 180 days from both the groups. Improvements in the KAP scores following the intervention was analyzed using Wilcoxon signed rank test at alpha = .05, and the feedback was obtained using a ‘Likert scale’ having 20 questions; maximum possible score was 100.

Results: The median (IQR) overall baseline scores of knowledge were 11 (10-12), the attitude/practice scores were 22 (20.25-22.00) and the total scores was 32.5 (31-34); the maximum possible score was 40. Almost all (n = 113; 97.4%) of them felt adverse drug reactions reporting was necessary and were interested in learning about adverse drug reactions. The baseline KAP scores were significantly higher among the second- and third-year students compared to the first year (p < .001). Upon intervention, a significant improvement was seen in knowledge scores between the baseline and first follow-up (p = .018) and between second and third follow-up (p = .001) in the test group. The median (IQR) feedback score was 85 (80.7-88.2).

Conclusions: Students had better attitude/practice scores, but a poor knowledge score at baseline. This study confirmed the feasibility of conducting a pharmacovigilance module for nursing students in Nepal.

Full Text:



Journal of Nursing Education and Practice

ISSN 1925-4040 (Print)   ISSN 1925-4059 (Online)

Copyright © Sciedu Press 
To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.